Displaying 85 - 96 of 496
Viral Hepatitis

What if Patients Have Advanced Liver Disease?

Webcasts
View
Viral Hepatitis

DAAre to Treat When There’s Polypharmacy

Webcasts
View
Viral Hepatitis

Treating Early Infections – What’s the Problem?

Webcasts
View
Viral Hepatitis

Close

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC as a Patient-Based Clinician

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC as a Patient-Based Clinician

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Personalised management of MASH (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)

Webcasts
View
Displaying 85 - 96 of 496